Monopar Therapeutics Inc. logo

Monopar Therapeutics Inc. (MNPR)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
111. 12
+2.6
+2.3959%
$
714.12M Market Cap
- P/E Ratio
- Div Yield
265,200 Volume
-0.65 Eps
$ 108.52
Previous Close
Analysts:
Add Transaction
Day Range
104 111.94
Year Range
29.18 112.57
Want to track MNPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bears are Losing Control Over Monopar Therapeutics (MNPR), Here's Why It's a 'Buy' Now

Bears are Losing Control Over Monopar Therapeutics (MNPR), Here's Why It's a 'Buy' Now

After losing some value lately, a hammer chart pattern has been formed for Monopar Therapeutics (MNPR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks | 2 years ago